APC Anti-Human CD122/IL-2RB Antibody[TU27]

Introducing the APC Anti-Human CD122/IL-2RB Antibody [TU27], a cutting-edge product designed to revolutionize the field of immunology. This antibody, available in a convenient size of 20 tests, is meticulously crafted to provide researchers with unparalleled accuracy and reliability in their experiments.

The APC Anti-Human CD122/IL-2RB Antibody [TU27] is specifically engineered to target the CD122/IL-2RB protein, a crucial component in the interleukin-2 receptor complex. By selectively binding to this protein, our antibody enables precise identification and analysis of CD122/IL-2RB expression in human samples.

With its advanced technology and exceptional specificity, this antibody offers researchers an invaluable tool for investigating the role of CD122/IL-2RB in various biological processes. Whether studying immune responses, T-cell activation, or cytokine signaling pathways, our antibody empowers scientists to delve deeper into the intricate mechanisms underlying these phenomena.

Furthermore, the APC conjugate of this antibody ensures enhanced sensitivity and fluorescence detection, facilitating accurate and efficient flow cytometry analysis. Its robust performance and consistent results make it an indispensable asset for any laboratory seeking to advance their understanding of immunology.

In addition to its scientific merits, the APC Anti-Human CD122/IL-2RB Antibody [TU27] is manufactured to the highest industry standards, guaranteeing exceptional quality and reproducibility. Rigorous quality control measures are implemented throughout the production process to ensure batch-to-batch consistency, ensuring reliable and consistent results every time.

In summary, the APC Anti-Human CD122/IL-2RB Antibody [TU27] is a state-of-the-art product that offers researchers an unparalleled opportunity to explore the intricacies of CD122/IL-2RB biology. Its advanced technology, exceptional specificity, and reliable performance make it an indispensable tool for any laboratory seeking to make groundbreaking discoveries in the field of immunology.